Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Historic blue plaque unveiled at Cellar Wines, Ripley, where pharmacist Kenneth White pioneered civilian use penicillin
  • USA - English


News provided by

Cellar Wines

Sep 30, 2016, 10:25 ET

Share this article

Share toX

Share this article

Share toX

Blue Plaque at Cellar Wines 1
Blue Plaque at Cellar Wines 1
Youtube
Youtube

Ripley, Surrey (PRWEB UK) 30 September 2016 -- Cellar Wines in Ripley played host last night to a memorable event which unveiled a prestigious, new blue plaque. Ripley Pharmacy on Ripley High Street, a former 15th century coaching inn, was bought by thirty-year-old chemist, Kenneth White, in 1943. It was here that White first made the wonder drug penicillin available to the public. The dispensary has had just four owners in 102 years, until it was bought by Cellar Wines in 2015.

not satisfied with the dictum "no penicillin for civilians"

Post this

The Mayor of Guildford, Councillor Gordon Jackson, unveiled the plaque, along with John Hutson, who had worked alongside White since 1944 and who continued to work at the pharmacy for fifty years. The event had a very good turnout, with guests including family members of Donald Green, who also worked with White.

Cellar Wines, an independent luxury brand provider, offering artisan spirits, boutique wines, a gourmet delicatessen and fantastic events, kindly sponsored the event. Cellar Wines were delighted to lay on a selection of their fine wines, cheeses and canapés from their delicatessen. The blue plaque now had pride of place on the wall outside the wine shop.

History behind White’s achievements

Penicillin had been discovered in 1928 by Scottish scientist Alexander Fleming and the production of penicillin became a wartime priority but it was reserved exclusively for the Armed Forces: None was made available to the civilian population. For months, White had wondered what he could do to help the war effort. He followed the discovery of penicillin with interest and, not satisfied with the dictum "no penicillin for civilians," he resolved to do something about it. White’s additional motivation to manufacture the drug came after he made a bet with a local doctor.

In a quiet back room of the now Grade II listed building, with its old-fashioned façade, timber frames and picturesque appearance, the ambitious young chemist defied the establishment to bring a medical revolution into the lives of ordinary people. To undertake the manufacture of penicillin, White needed a suitable strain of ‘penicillium notatum’. He evidently did acquire one but how and when he did so remains unknown. In March 1944, White wrote to the Ministry of Supply requesting a ‘pure culture’. In July of the same year, he wrote to the National Collection of Type Cultures with a similar appeal: both requests were rejected. Apparently, an embargo had been placed on this particular culture to prevent scientists from other countries getting hold of it.

Apparently, White told a newspaper reporter that he had visited a large penicillin manufacturing facility and in all likelihood, he was secretly given a culture during his visit. In April 1944, using culture flasks, an ice-cream refrigerator borrowed from a local tea shop (after food rationing had rendered it redundant) and a great deal of resourcefulness and help from locals, White became the first civilian chemist to manufacture penicillin filtrate.

An article in The Daily Mirror, 3rd June 1944, reported:

Youthful, energetic, Mr. White leads a "double existence." In the day time he supplied the villagers with medicine; far into the night he worked in the dispensary at the rear of his shop to supply hospitals and doctors with free penicillin.

The early penicillin was not suitable for injecting so White made it into a cream. Perfecting his technique, by September 1946, White had acquired a special license to dispense penicillin injections. Supplies were soon available for local doctors, hospitals, nursing homes, veterinary surgeons and pharmacists.

Inevitably, the appearance of stories in the press about White’s success with penicillin led to pleas from members of the public, desperate to obtain the powerful antibiotic for friends and relatives. His efforts are believed to have led to the treatment of a few score of patients and all the evidence suggests that he bore all the associated production costs himself and made no charge for the penicillin.

White’s humanitarian spirit and Herculean efforts were also greeted with admiration by a number of drug houses. In recognition of his achievements, Glaxo Laboratories supplied him with growth medium in tablet form for cultivating penicillin. In February 1945, the Ministry of Supply sent White a coveted culture, a gesture tantamount to their bestowing official approval on his endeavours.

White was continually attempting to improve his production facilities. White had attempted, without success, to obtain a licence under the terms of the Therapeutic Substances Act, 1925 to conduct research into penicillin. This was withheld during the war and finally granted in July 1948.

Working almost completely independently and unaffiliated to either a hospital, academic institution or research organisation, White succeeded in producing penicillin for the general public. Learning of the existence of a compound that had the power to alleviate human suffering, he determined to do what he could, with the limited resources available to him, to provide a much-needed antibiotic to as many people as possible. White continued making and supplying penicillin after the war had ended.

more info:

https://www.cellarwines.co.uk/history-of-the-building/

https://www.cellarwines.co.uk/historic-blue-plaque-unveiled-at-cellar-wines-ripley/

Andy Walton, Cellar Wines, http://www.cellarwines.co.uk, +44 1483610610, [email protected]

Modal title

Cellar Wines Blue Plaque Press Release 30/09/16
View PDF
Cellar Wines Blue Plaque Press Release 30/09/16
Blue Plaque at Cellar Wines 1
Blue Plaque at Cellar Wines 1
Blue Plaque at Cellar Wines
Blue Plaque at Cellar Wines
Plaques at Cellar Wines
Plaques at Cellar Wines
Blue Plaque at Cellar Wines 2
Blue Plaque at Cellar Wines 2
Kenneth White
Kenneth White
The Pharmacy, est late 1940/early 1950
The Pharmacy, est late 1940/early 1950
Information Board 1
View PDF
Information Board 1
Information Board 2
View PDF
Information Board 2
Information Board 3
View PDF
Information Board 3
Information Board 4
View PDF
Information Board 4
Cellar Wines Blue Plaque Press Release 30/09/16 Blue Plaque at Cellar Wines 1 Blue Plaque at Cellar Wines Plaques at Cellar Wines Blue Plaque at Cellar Wines 2 Kenneth White The Pharmacy, est late 1940/early 1950 Information Board 1 Information Board 2 Information Board 3 Information Board 4

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.